Corcept Therapeutics, Inc. (CORT)
110.94
-3.98
(-3.46%)
USD |
NASDAQ |
Sep 11, 12:53
Corcept Therapeutics Gross Profit (TTM) : 816.73M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 816.73M |
| March 31, 2026 | 755.64M |
| December 31, 2025 | 748.43M |
| September 30, 2025 | 727.78M |
| June 30, 2025 | 704.42M |
| March 31, 2025 | 674.70M |
| December 31, 2024 | 664.16M |
| September 30, 2024 | 618.75M |
| June 30, 2024 | 561.03M |
| March 31, 2024 | 515.90M |
| December 31, 2023 | 475.89M |
| September 30, 2023 | 443.94M |
| June 30, 2023 | 422.37M |
| March 31, 2023 | 408.30M |
| December 31, 2022 | 396.47M |
| September 30, 2022 | 392.36M |
| June 30, 2022 | 386.83M |
| March 31, 2022 | 374.97M |
| December 31, 2021 | 360.70M |
| September 30, 2021 | 347.71M |
| June 30, 2021 | 337.96M |
| March 31, 2021 | 335.09M |
| December 31, 2020 | 348.29M |
| September 30, 2020 | 350.27M |
| June 30, 2020 | 345.21M |
| Date | Value |
|---|---|
| March 31, 2020 | 328.76M |
| December 31, 2019 | 300.98M |
| September 30, 2019 | 279.78M |
| June 30, 2019 | 262.86M |
| March 31, 2019 | 253.14M |
| December 31, 2018 | 246.03M |
| September 30, 2018 | 232.90M |
| June 30, 2018 | 211.55M |
| March 31, 2018 | 185.18M |
| December 31, 2017 | 155.65M |
| September 30, 2017 | 126.77M |
| June 30, 2017 | 106.04M |
| March 31, 2017 | 90.56M |
| December 31, 2016 | 79.26M |
| September 30, 2016 | 70.62M |
| June 30, 2016 | 62.56M |
| March 31, 2016 | 54.78M |
| December 31, 2015 | 48.92M |
| September 30, 2015 | 43.08M |
| June 30, 2015 | 37.12M |
| March 31, 2015 | 31.24M |
| December 31, 2014 | 25.67M |
| September 30, 2014 | 20.97M |
| June 30, 2014 | 16.52M |
| March 31, 2014 | 12.75M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Liquidia Corp. | 416.18M |
| Eli Lilly & Co. | 66.44B |
| Indivior Pharmaceuticals, Inc. | 1.116B |
| Crinetics Pharmaceuticals, Inc. | 36.49M |
| Merck & Co., Inc. | 48.01B |